alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
SENATE OF THE UNITED STATES 

ONE HUNDREDTH CONGRESS 

Convened January 6, 1987 

FIRST SESSION { 

SECOND SESSION { 

EXECUTIVE CALENDAR 

Tuesday, June 2, 1987 

PREPARED UNDER THE DIRECTION OF WALTER J. STEWART, 

SECRETARY OF THE SENATE 

By Gerald A. Hackett, Executive Clerk 
Calendar 

Ne\ 

1 

2 

Calendar 

No. 

* 78 

Treaty 

Doc. No. 

EX. 

N(A), 

94-2 

EX. 

N(B), 

94-2 

Message 

No. 

73-2 

1 

TREATIES 

Subject 

Treaty with the Umon of Soviet Socialist 

Republics on the Limitation of Underground 

Nuclear Weapon Tests, and the Protocol 

thereto (Threshold Test Ban Treaty). 

Treaty with the Umon of Soviet Socialist 

Republics on Underground Nuclear 

Explosions for Peaceful Purposes, and the 

Protocol thereto (Peaceful Nuclear 

Explosions Treaty). 

NOMINATIONS 

Nominee, Office, And Predecessor 

DEPARTMENT OF STATE 

Melissa Foelsch Wells, of New York, a 

Career Member of the Senior Foreign 

Service, Class of Minister-Counselor, to 

be Ambassador Extraordinary and 

Plenipotentiary of the United States of 

America to the People's Republic of 

Mozambique. 

Reported 

By 

Feb 27 87 Reported 

favorably, with a 

resolution of advice and 

consent to ratification 

with a reservation and a 

declaration, by Mr. Pell, 

Committee on Foreign 

Relations (Printed Report 

together with additional 

views-Ex. Rept 100-1) 

Feb 27 87 Reported 

favorably, with a 

resolution of advice and 

consent to ratification 

with a reservation and a 

declaration, by Mr. Pell, 

Committee on Foreign 

Relations (Printed report 

together with additional 

views--Ex. Rept. 100-1) 

Reported 

Bv 

Mar 31, 87 Mr. Pell, 

Committee on Foreign 

Relations, without pnnted 

report 
2 

-

Calendar Message Nominee, Office, And Predecessor Reported 

No. No. By 

DEPARTMENT OF HEALTH AND HUMAN 

SERVICES 

" 88 122 Jean K. Elder, of Virginia, to be an Apr 28, 87 Mr. Bentsen, Assistant Secretary of Health and Human Committee on Finance, 

Services, vice Dorcas R. Hardy, resigned. without printed report 

THE JUD ICIARY 

90 98 David Bryan Sentelle, of North Carolina, to May 1, 87 Mr. Byrd, for Mr. 

be United States Circuit Judge for the Biden, Committee on the 

District of Columbia Circuit vice Antonin Judiciary, without printed 

Scalia, elevated. report 

[NEW REPORTS ] 

ARMY 

171 170 The following- named officer under the May 29, 87 Mr. Nunn, 

provisions of Title 10. United States Committee on Armed 

Code, Section 601, to be ~igned to a Services, without printed 

position of importance and responsibility report 

designated by the President under Title 

10, United States Code, Section 601: 

to be General 

Gen. John R. Galvin, - United 

States Armv. .. •S1gmf1es nom1nee's commitment to respond to requests to appear and testify before any duly 

constituted committee of the Senate.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report for Rainchief Energy Inc. (the“Company”) on

Form 20-F for the year ended December 31, 2012 as filed with theSecurities and Exchange

Commission on the date hereof (the “Report), the undersigned,Paul E. Heney, Chief Executive Officer do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes- Oxley Act of 2002, that to the best of our knowledge:

 

 

(1)	The Report fully complies with the requirements of section13(a) of the Securities

Exchange Act of 1934; and

 

(2)	The information contained in the Report fairly presents, inall material respects, the

Financial condition and results of operationsof the Company.

 

 

By:

 

 

/s/ Paul E. Heney

Paul E. Heney

Chief Executive Officer

June 25, 2013
<PAGE>   1

                                                                      EXHIBIT 11

               AMERICAN NATIONAL FINANCIAL, INC. AND SUBSIDIARIES
                        COMPUTATION OF BASIC AND DILUTED
                               EARNINGS PER SHARE
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>
                                         THREE MONTHS ENDED       SIX MONTHS ENDED
                                              JUNE 30,                JUNE 30,
                                         ------------------      ------------------
                                          2000        1999        2000        1999
                                         ------      ------      ------      ------
<S>                                      <C>         <C>         <C>         <C>
Net earnings, basic basis .........      $  643      $2,647      $  311      $5,443
                                         ======      ======      ======      ======
Weighted average basic shares .....       7,312       7,150       7,270       6,606
                                         ------      ------      ------      ------
Basic earnings per share ..........      $ 0.09      $ 0.37      $ 0.04      $ 0.82
                                         ======      ======      ======      ======

Diluted net earnings ..............      $  643      $2,647      $  311      $5,443
                                         ======      ======      ======      ======
Weighted average shares outstanding
  during the period, basic basis ..       7,312       7,150       7,270       6,606

Effect of dilutive options ........          --          --          --          66
                                         ------      ------      ------      ------
Weighted average shares outstanding
  during the period, diluted basis        7,312       7,150       7,270       6,672
                                         ======      ======      ======      ======

Diluted earnings per share ........      $ 0.09      $ 0.37      $ 0.04      $ 0.82
                                         ======      ======      ======      ======
</TABLE>
Exhibit 10.4
  
  IMPLANT SCIENCES CORPORATION
  AMENDMENT TO 2004 STOCK OPTION PLAN
  MARCH 14, 2011
  This Amendment to the 2004 Stock Option Plan(this “Amendment”) of Implant Sciences Corporation, a Massachusetts corporation (the “Corporation”), is effective as of March 14, 2011.
  1.
Section 4.1 of the Corporation’s 2004 Stock Option Plan is hereby deleted in its entirety and replaced with the following:
  “4.1           Maximum Number of Shares Issuable.  Subject to adjustment as provided in Section 4.2, the maximum aggregate number of shares of Stock that may be issued under the Plan shall be four million (4,000,000) and shall consist of authorized but unissued or reacquired shares of Stock, treasury shares or any combination thereof.  If an outstanding Option for any reason expires or is terminated or canceled or if shares of Stock are acquired upon the exercise or Award of an Option, the shares of Stock allocable to the unexercised portion of such Option or such repurchased shares of Stock shall again be available for issuance under the Plan.”
  2.
This Amendment shall be governed by and construed according to the laws of the Commonwealth of Massachusetts.
  3.
All other terms of the 2004 Stock Option Plan shall remain in full force and effect.
  This Amendment was approved by the Board of Directors of the Corporation effective as of March 14, 2011 and by the stockholders of the Corporation effective as of __________.
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

I, Michael J. Dodak, the Chief Executive Officer of FNDS3000 Corp (the Company), certify, pursuant to
Section 906 of the

Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

(1) the Annual Report on Form 10-KSB of the Company for the fiscal year ended August 31, 2008 (the Report) fully complies with the requirements of
Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) the information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                        |  |                               
|----------------------- |  | ------------------------------
|Dated: December 3, 2008 |  | /s/ Michael J. Dodak          
|                        |  | Name: Michael J. Dodak        
|                        |  | Title: Chief Executive Officer
##### 



Exhibit 10.5
 Certain information in this document, marked by brackets, has been omitted and filed separately
with the Securities and Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions.
 (MAXYGEN LOGO)
    
    Maxygen, Inc.
515 Galveston Drive
Redwood City, CA 94063
650.298.5300 main
650.364.2715 fax
www.maxygen.com
  
 Re:
    
    License Agreement effective as of March 28, 2002, by and between
Maxygen, Inc. and Codexis, Inc., as amended (the Agreement)
  Exhibit G
 SubField 8
 a.
    
    Manufacture of fuel and/or fuel additives and/or lubricants, where Biomass
(as defined below) is the starting material for the applicable fuel and/or fuel
additive and/or lubricant, including without limitation the manufacture of compounds
(e.g., fermentable sugars) which are intermediates in the process of producing fuel or
fuel additives and/or lubricants, where Biomass is the starting material for the
applicable fuel and/or fuel additive and/or lubricant and such intermediates are used
solely in the production of fuel or fuel additives and/or lubricants, but specifically
excluding the fuels and/or fuel additives and/or lubricants in Category (b) below.b.
    
    Conversion of Biomass-derived oils into fuel and/or fuel additives and/or
lubricants, including without limitation the manufacture of compounds which are
intermediates in the process of converting Biomass-derived oils into fuel and/or fuel
additives and/or lubricants, where such intermediates are used solely in the
production of fuel or fuel additives and/or lubricants.
 [****]
 
 *
    
    Certain information on this page has been omitted and filed
separately with the Securities and Exchange Commission. Confidential treatment
has been requested with respect to the omitted portions.




---



##### 



Biomass [****]
 [****] [****]
    Yours sincerely,/s/ Michael S. RabsonMichael S. Rabson UNDERSTOOD AND AGREED
BY CODEXIS, INC.By:
    /s/ Douglas SheehyName:
    Douglas SheehyTitle:  Date:
    VP & General Counsel
 September 24, 2007 
 *
    
    Certain information on this page has been omitted and filed
separately with the Securities and Exchange Commission. Confidential treatment
has been requested with respect to the omitted portions.
Fourth Court of Appeals

San Antonio, Texas

April 2, 2014

No. 04-14-00106-CR

EX PARTE Otto Ray KIETZMAN,

From the Criminal District Court, Magistrate Court, Bexar County, Texas

Trial Court No. 2013W0631

Honorable Andrew Carruthers, Judge Presiding

ORDER

In accordance with this Court’s memorandum opinion of this date, the appeal is 

DISMISSED FOR LACK OF JURISDICTION. 

It is so ORDERED on April 2, 2014.

_____________________________

Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 2nd day of April, 2014.

_____________________________

Keith E. Hottle, Clerk
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Research Resources Special Emphasis Panel; RCMI Teleconference (II).                    

*Date:*                         December 6, 2006.                    

*Time:*                         2 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Guo Zhang, PhD, MPH, Scientific Review Administrator, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Boulevard, 1 Democracy Plaza, Room 1064, Bethesda, MD 20892, (301) 435-0812,                         *zhanggu@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS)

Dated: November 14, 2006.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 06-9320 Filed 11-20-06; 8:45 am]

BILLING CODE 4140-01-M
#### § 158.121 Newer experience.

If, for any aggregation as defined in § 158.120, 50 percent or more of the total earned premium for an MLR reporting year is attributable to policies newly issued in that MLR reporting year, then the experience of these policies may be excluded from the report required under § 158.110 for that same MLR reporting year. If an issuer chooses to defer reporting of newer business as provided in this section, then the excluded experience must be added to the experience reported in the following MLR reporting year.

[81 FR 94183, Dec. 22, 2016]
EXHIBIT 31.3



Certification of Chief Executive Officer
Pursuant to

Securities Exchange Act Rules 13a-14(a)
and 15d-14(a)

as Adopted Pursuant to

Section 302 of the Sarbanes-Oxley
Act of 2002



I, Oli Valur Steindorsson, certify that:



| | 1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Umami Sustainable
Seafood Inc. for the year ended June 30, 2012; and
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Dated: October 29, 2012



| | By: | /s/ Oli Valur Steindorsson
| | --- | --------------------------
| |     | Oli Valur Steindorsson    
| |     | Chief Executive Officer
§ 164.310 Physical safeguards. A covered entity or business associate must, in accordance with § 164.306: ( a ) ( 1 ) *Standard: Facility access controls.* Implement policies and procedures to limit physical access to its electronic information systems and the facility or facilities in which they are housed, while ensuring that properly authorized access is allowed.
( 2 ) *Implementation specifications:* ( i ) *Contingency operations (Addressable).* Establish (and implement as needed) procedures that allow facility access in support of restoration of lost data under the disaster recovery plan and emergency mode operations plan in the event of an emergency.
( ii ) *Facility security plan (Addressable).* Implement policies and procedures to safeguard the facility and the equipment therein from unauthorized physical access, tampering, and theft.
( iii ) *Access control and validation procedures (Addressable).* Implement procedures to control and validate a person's access to facilities based on their role or function, including visitor control, and control of access to software programs for testing and revision.
( iv ) *Maintenance records (Addressable).* Implement policies and procedures to document repairs and modifications to the physical components of a facility which are related to security (for example, hardware, walls, doors, and locks).
( b ) *Standard: Workstation use.* Implement policies and procedures that specify the proper functions to be performed, the manner in which those functions are to be performed, and the physical attributes of the surroundings of a specific workstation or class of workstation that can access electronic protected health information.
( c ) *Standard: Workstation security.* Implement physical safeguards for all workstations that access electronic protected health information, to restrict access to authorized users.
( d ) ( 1 ) *Standard: Device and media controls.* Implement policies and procedures that govern the receipt and removal of hardware and electronic media that contain electronic protected health information into and out of a facility, and the movement of these items within the facility.
( 2 ) *Implementation specifications:* ( i ) *Disposal (Required).* Implement policies and procedures to address the final disposition of electronic protected health information, and/or the hardware or electronic media on which it is stored.
( ii ) *Media re-use (Required).* Implement procedures for removal of electronic protected health information from electronic media before the media are made available for re-use.
( iii ) *Accountability (Addressable).* Maintain a record of the movements of hardware and electronic media and any person responsible therefore.
( iv ) *Data backup and storage (Addressable).* Create a retrievable, exact copy of electronic protected health information, when needed, before movement of equipment.
[68 FR 8376, Feb. 20, 2003, as amended at 78 FR 5694, Jan. 25, 2013]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 562b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, SBIR Topic 220, “Chemical Optomization and Structure-Activity Relationship”.                    

*Date:*                         March 9, 2006.                    

*Time:*                         11:45 a.m. to 1:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Marvin L. Salin, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, 6116 Executive Boulevard, Room 7073, MSC8329, Bethesda, MD 20892-8329, 301-496-0694,                         *msalin@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 24, 2006.

Anna Snouffer, 

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 06-912 Filed 1-31-06; 8:45 am]

BILLING CODE 4140-01-M
1... This proceeding arises out of Cause No. 2009-CVF-001058 D2, styled Manuel Rios Herrera v. Compass

Bank, As Successor in Interest to The Laredo National Bank, filed in the 111th Judicial District Court, Webb County,

Texas. 

i i i i i i

MEMORANDUM OPINION

No. 04-10-00182-CV

IN RE MANUEL RIOS HERRERA

Original Mandamus Proceeding1

PER CURIAM

Sitting: Sandee Bryan Marion, Justice

Rebecca Simmons, Justice

Marialyn Barnard, Justice

Delivered and filed: April 21, 2010

PETITION FOR WRIT OF MANDAMUS DENIED

On March 1, 2010, relator filed a petition for writ of mandamus, complaining of the trial

court’s order dated January 25, 2010. This court’s review of the transcript of the January 20, 2010

hearing and the trial court’s docket entry dated January 20, 2010 indicates the parties reached an

agreement that led to the January 25, 2010 order. Accordingly, this court has determined relator is

not entitled to the relief sought. Therefore, the petition is DENIED. TEX. R. APP. P. 52.8(a).

Relator shall pay all costs incurred in this proceeding.

PER CURIAM